nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—AGTR1—dilated cardiomyopathy	0.933	1	CbGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0107	0.185	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00835	0.144	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00451	0.0777	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00385	0.0664	CbGpPWpGaD
Forasartan—Tasosartan—AGTR2—dilated cardiomyopathy	0.00341	0.381	CrCbGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00244	0.0421	CbGpPWpGaD
Forasartan—AGTR1—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.00185	0.0318	CbGpPWpGaD
Forasartan—AGTR1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.00146	0.0251	CbGpPWpGaD
Forasartan—AGTR1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.00141	0.0243	CbGpPWpGaD
Forasartan—AGTR1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00139	0.024	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.00134	0.0231	CbGpPWpGaD
Forasartan—AGTR1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00129	0.0223	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00122	0.021	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.00119	0.0206	CbGpPWpGaD
Forasartan—Tasosartan—AGTR1—dilated cardiomyopathy	0.00118	0.132	CrCbGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.00108	0.0186	CbGpPWpGaD
Forasartan—Valsartan—AGTR1—dilated cardiomyopathy	0.00102	0.114	CrCbGaD
Forasartan—Olmesartan—AGTR1—dilated cardiomyopathy	0.000999	0.111	CrCbGaD
Forasartan—AGTR1—Allograft Rejection—IL10—dilated cardiomyopathy	0.00085	0.0147	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.00079	0.0136	CbGpPWpGaD
Forasartan—Irbesartan—AGTR1—dilated cardiomyopathy	0.000777	0.0867	CrCbGaD
Forasartan—Candesartan—AGTR1—dilated cardiomyopathy	0.000777	0.0867	CrCbGaD
Forasartan—AGTR1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000762	0.0131	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000654	0.0113	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000654	0.0113	CbGpPWpGaD
Forasartan—AGTR1—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000652	0.0112	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000608	0.0105	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000512	0.00883	CbGpPWpGaD
Forasartan—Losartan—AGTR1—dilated cardiomyopathy	0.0005	0.0559	CrCbGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000476	0.0082	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000467	0.00804	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000461	0.00795	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000439	0.00756	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000439	0.00756	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000408	0.00703	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000395	0.00681	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000373	0.00644	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000358	0.00618	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000354	0.0061	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000334	0.00576	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000334	0.00576	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000324	0.00558	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00032	0.00553	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00032	0.00552	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00031	0.00535	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000301	0.00518	CbGpPWpGaD
Forasartan—Losartan—ACE—dilated cardiomyopathy	0.000289	0.0323	CrCbGaD
Forasartan—AGTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000244	0.0042	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000237	0.00409	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000222	0.00383	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000189	0.00325	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000189	0.00325	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000181	0.00312	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000175	0.00302	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000171	0.00295	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000171	0.00295	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00017	0.00293	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000159	0.00275	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000154	0.00266	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000153	0.00263	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000138	0.00237	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000125	0.00216	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000114	0.00197	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000107	0.00184	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000102	0.00176	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000101	0.00175	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000101	0.00175	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.71e-05	0.00167	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.41e-05	0.00162	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.27e-05	0.0016	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.11e-05	0.00157	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.39e-05	0.00127	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.44e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.35e-05	0.00109	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.73e-05	0.000989	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGT—dilated cardiomyopathy	5.48e-05	0.000945	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.41e-05	0.000761	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.8e-05	0.000655	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.61e-05	0.00045	CbGpPWpGaD
